Blockade of MUC1 expression by glycerol guaiacolate inhibits proliferation of human breast cancer cells

Anti-Cancer Agents in Medicinal Chemistry

Volumn 10, Issue 8, 2010, Pages 644-650

  Smith, J S ^a   Colon, J ^a   Madero Visbal, R ^a   Isley, B ^a   Konduri, S D ^a,b   Baker, C H ^b  

^a M D ANDERSON CANCER CENTER ORLANDO   (United States)

^b UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Breast cancer; Glycerol guaiacolate; MUC1

Indexed keywords

GUAIFENESIN; KI 67 ANTIGEN; MESSENGER RNA; MUCIN 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN P21;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER SIZE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG INHIBITION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOUSE; NONHUMAN; OVARIECTOMY; PROTEIN EXPRESSION; TREATMENT OUTCOME;

EID: 79551649932     PISSN: 18715206     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152010794473984     Document Type: Article

References (26)

1. Perez-Vilar, J.; Hill, R. L. The structure and assembly of secreted mucins. J. Biol. Chem., 1999, 274(45), 31751-4.
2. Gendler, S. J. MUC1, the renaissance molecule. J. Mammary Gland Biol. Neoplasia, 2001, 6(3), 339-53.
3. Kufe, D. W. Mucins in cancer: function, prognosis and therapy. Nat. Rev. Cancer, 2009, 9(12), 874-85.
4. Boshell, M.; Lalani, E. N.; Pemberton, L.; Burchell, J.; Gendler, S.; Taylor-Papadimitriou, J. The product of the human MUC1 gene when secreted by mouse cells transfected with the full-length cDNA lacks the cytoplasmic tail. Biochem. Biophys. Res. Commun., 1992, 185(1), 1-8.
5. Burchell, J.; Wang, D.; Taylor-Papadimitriou, J. Detection of the tumour-associated antigens recognized by the monoclonal antibodies HMFG-1 and 2 in serum from patients with breast cancer. Int. J. Cancer, 1984, 34(6), 763-8.
6. Zotter, S.; Hageman, P. C.; Lossnitzer, A.; van den Tweel, J.; Hilkens, J.; Mooi, W. J.; Hilgers, J. Monoclonal antibodies to epithelial sialomucins recognize epitopes at different cellular sites in adenolymphomas of the parotid gland. Int. J. Cancer Suppl., 1988, 3, 38-44.
7. McGuckin, M. A.; Devine, P. L.; Ramm, L. E.; Ward, B. G. Factors effecting the measurement of tumor-associated MUC1 mucins in serum. Tumour Biol., 1994, 15(1), 33-44.
8. Zhang, K.; Baeckstrom, D.; Brevinge, H.; Hansson, G. C. Secreted MUC1 mucins lacking their cytoplasmic part and carrying sialyl-Lewis a and x epitopes from a tumor cell line and sera of colon carcinoma patients can inhibit HL-60 leukocyte adhesion to Eselectin-expressing endothelial cells. J. Cell Biochem., 1996, 60(4), 538-49.
9. Metzgar, R. S.; Rodriguez, N.; Finn, O. J.; Lan, M. S.; Daasch, V. N.; Fernsten, P. D.; Meyers, W. C.; Sindelar, W. F.; Sandler, R. S.; Seigler, H. F. Detection of a pancreatic cancer-associated antigen (DU-PAN-2 antigen) in serum and ascites of patients with adenocarcinoma. Proc. Natl. Acad. Sci. USA, 1984, 81(16), 5242-6.
10. Pemberton, L.; Taylor-Papadimitriou, J.; Gendler, S. J. Antibodies to the cytoplasmic domain of the MUC1 mucin show conservation throughout mammals. Biochem. Biophys. Res. Commun., 1992, 185(1), 167-75.
11. Treon, S. P.; Maimonis, P.; Bua, D.; Young, G.; Raje, N.; Mollick, J.; Chauhan, D.; Tai, Y. T.; Hideshima, T.; Shima, Y.; Hilgers, J.; von Mensdorff-Pouilly, S.; Belch, A. R.; Pilarski, L. M.; Anderson, K. C. Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myeloma. Blood, 2000, 96(9), 3147-53.
12. Spicer, A. P.; Parry, G.; Patton, S.; Gendler, S. J. Molecular cloning and analysis of the mouse homologue of the tumor-associated mucin, MUC1, reveals conservation of potential O-glycosylation sites, transmembrane, and cytoplasmic domains and a loss of minisatellite-like polymorphism. J. Biol. Chem., 1991, 266(23), 15099-109.
13. Gaemers, I. C.; Vos, H. L.; Volders, H. H.; van der Valk, S. W.; Hilkens, J. A stat-responsive element in the promoter of the episialin/MUC1 gene is involved in its overexpression in carcinoma cells. J. Biol. Chem., 2001, 276(9), 6191-9.
14. Kovarik, A.; Lu, P. J.; Peat, N.; Morris, J.; Taylor-Papadimitriou, J. Two GC boxes (Sp1 sites) are involved in regulation of the activity of the epithelium-specific MUC1 promoter. J. Biol. Chem., 1996, 271(30), 18140-7.
15. Kovarik, A.; Peat, N.; Wilson, D.; Gendler, S. J.; Taylor-Papadimitriou, J. Analysis of the tissue-specific promoter of the MUC1 gene. J. Biol. Chem., 1993, 268(13), 9917-26.
16. Zaretsky, J. Z.; Weiss, M.; Tsarfaty, I.; Hareuveni, M.; Wreschner, D. H.; Keydar, I. Expression of genes coding for pS2, c-erbB2, estrogen receptor and the H23 breast tumor-associated antigen. A comparative analysis in breast cancer. FEBS Lett., 1990, 265(1-2), 46-50.
17. Joshi, M. D.; Ahmad, R.; Yin, L.; Raina, D.; Rajabi, H.; Bubley, G.; Kharbanda, S.; Kufe, D. MUC1 oncoprotein is a druggable tar-get in human prostate cancer cells. Mol. Cancer Ther., 2009, 8(11), 3056-65.
18. Raina, D.; Ahmad, R.; Joshi, M. D.; Yin, L.; Wu, Z.; Kawano, T.; Vasir, B.; Avigan, D.; Kharbanda, S.; Kufe, D. Direct targeting of the mucin 1 oncoprotein blocks survival and tumorigenicity of human breast carcinoma cells. Cancer Res., 2009, 69(12), 5133-41.
19. Kalra, A. V.; Campbell, R. B., Mucin impedes cytotoxic effect of 5-FU against growth of human pancreatic cancer cells: overcoming cellular barriers for therapeutic gain. Br. J. Cancer 2007, 97(7), 910-8.
20. Ligtenberg, M. J.; Kruijshaar, L.; Buijs, F.; van Meijer, M.; Litvinov, S. V.; Hilkens, J., Cell-associated episialin is a complex containing two proteins derived from a common precursor. J. Biol. Chem., 1992, 267(9), 6171-7.
21. Kufe, D.; Inghirami, G.; Abe, M.; Hayes, D.; Justi-Wheeler, H.; Schlom, J. Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Hybridoma, 1984, 3(3), 223-32.
22. Bitler, B. G.; Menzl, I.; Huerta, C. L.; Sands, B.; Knowlton, W.; Chang, A.; Schroeder, J. A., Intracellular MUC1 peptides inhibit cancer progression. Clin. Cancer Res., 2009, 15(1), 100-9.
23. Augereau, P.; Miralles, F.; Cavailles, V.; Gaudelet, C.; Parker, M.; Rochefort, H., Characterization of the proximal estrogenresponsive element of human cathepsin D gene. Mol. Endocrinol., 1994, 8(6), 693-703.
24. Bourguet, W.; Ruff, M.; Chambon, P.; Gronemeyer, H.; Moras, D. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature, 1995, 375(6530), 377-82.
25. Wei, X.; Xu, H.; Kufe, D. Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response. Cancer Cell, 2005, 7(2), 167-78.
26. Liu, W.; Konduri, S. D.; Bansal, S.; Nayak, B. K.; Rajasekaran, S. A.; Karuppayil, S. M.; Rajasekaran, A. K.; Das, G. M. Estrogen receptor-alpha binds p53 tumor suppressor protein directly and represses its function. J. Biol. Chem., 2006, 281(15), 9837-40.